◆英語タイトル:Surface Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013386
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Surface Oncology Inc (Surface Oncology) is a biopharmaceutical company that develops novel cancer immunotherapies for the treatment of cancer. The company develops treatments in which the immune system can be harnessed to fight cancer. It conducts pre-clinical study through new approaches to enhance the effectiveness of antigen presentation; to restrict the activity of suppressor cells in the tumor microenvironment; and to counter the effect of specific inhibitory cytokines and metabolites. The company provides monotherapies, checkpoint inhibitors and cancer vaccines. It develops pipeline of next-generation immunotherapies that provides treatment for patients suffering from cancer. Surface Oncology is headquartered in Cambridge, Massachusetts, the US.
Surface Oncology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Surface Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Surface Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Surface Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Surface Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Surface Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Surface Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Surface Oncology Raises USD35 Million in Series A Financing 10
Partnerships 12
Adimab Enters into Agreement with Surface Oncology 12
Licensing Agreements 13
Surface Oncology Enters into Licensing Agreement with Ligand Pharma 13
Surface Oncology Enters into Licensing Agreement with Novartis 14
Surface Oncology Inc – Key Competitors 15
Surface Oncology Inc – Key Employees 16
Surface Oncology Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Jun 19, 2017: Surface Oncology Expands Scientific Advisory Board with the Addition of Leading Clinical and Translational Cancer Immunotherapy Experts 18
Feb 06, 2017: Surface Oncology Appoints Jeff Goater as Chief Business Officer 19
Jan 04, 2017: Surface Oncology Welcomes Industry Leader Daniel S. Lynch as Chairman of Board of Directors 20
Jan 28, 2016: Vito Palombella, PhD Joins Surface Oncology as Chief Scientific Officer 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Surface Oncology Inc, Pharmaceuticals & Healthcare, Key Facts 2
Surface Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Surface Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Surface Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Surface Oncology Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Surface Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Surface Oncology Raises USD35 Million in Series A Financing 10
Adimab Enters into Agreement with Surface Oncology 12
Surface Oncology Enters into Licensing Agreement with Ligand Pharma 13
Surface Oncology Enters into Licensing Agreement with Novartis 14
Surface Oncology Inc, Key Competitors 15
Surface Oncology Inc, Key Employees 16